Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
Clinical trial NCT02192541 · TERMINATED
Trial details
- NCT number
- NCT02192541
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-02
- Primary completion
- 2016-02-25
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.